PTGX
#948
Protagonist Therapeutics, Inc. - Common Stock
138.6 0 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.33%
Changement Mensuel
-7.55%
Evolution sur 6 mois
+42.04%
Changement Annuel
+84.48%
Clôture Précédente
144.8 8
Open
146.0 0
Low
137.8 8
High
146.0 0
Financials
- Market Capitalization 8.97 B
- Employee 141
- Founded 2006
- CEO N/A
- Website www.protagonist-inc.com
- Headquarter Delaware, United States
- FIGI BBG002B63KM7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-42.6
ratio cours/chiffre d'affaires
120.66
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 894 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.45 USD | -1.00% | +1.76% | +0.72% | +97.88% | 9.98 B USD | ||
| 920 |  KRYS Krystal Biotech, Inc. - Common Stock | 321.09 USD | -3.31% | -1.75% | -8.46% | +71.59% | 9.50 B USD | ||
| 955 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 106.74 USD | -4.76% | +0.72% | -7.98% | +80.61% | 8.88 B USD | ||
| 970 |  CYTK Cytokinetics, Incorporated - Common Stock | 61.62 USD | -1.86% | +0.44% | -16.17% | +6.06% | 8.57 B USD |